CLGN
Price
$5.48
Change
+$0.07 (+1.29%)
Updated
Apr 25, 6:59 PM EST
28 days until earnings call
HOOK
Price
$0.81
Change
-$0.04 (-4.71%)
Updated
Apr 25, 6:59 PM EST
20 days until earnings call
Ad is loading...

Compare predictions CLGN vs HOOK

Header iconCLGN vs HOOK Comparison
Open Charts CLGN vs HOOKBanner chart's image
CollPlant Biotechnologies
Price$5.48
Change+$0.07 (+1.29%)
Volume$5.33K
CapitalizationN/A
HOOKIPA Pharma
Price$0.81
Change-$0.04 (-4.71%)
Volume$957.01K
CapitalizationN/A
View a ticker or compare two or three
CLGN vs HOOK Comparison Chart

Loading...

HOOKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CLGN vs. HOOK commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Buy and HOOK is a Hold.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (CLGN: $5.41 vs. HOOK: $0.85)
Brand notoriety: CLGN and HOOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 15% vs. HOOK: 1341%
Market capitalization -- CLGN: $61.97M vs. HOOK: $84.11M
CLGN [@Biotechnology] is valued at $61.97M. HOOK’s [@Biotechnology] market capitalization is $84.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileHOOK’s FA Score has 1 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • HOOK’s FA Score: 1 green, 4 red.
According to our system of comparison, HOOK is a better buy in the long-term than CLGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOOK’s TA Score shows that 5 TA indicator(s) are bullish.

  • HOOK’s TA Score: 5 bullish, 4 bearish.

Price Growth

CLGN (@Biotechnology) experienced а +3.24% price change this week, while HOOK (@Biotechnology) price change was +11.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.02%. For the same industry, the average monthly price growth was -8.35%, and the average quarterly price growth was +1260.86%.

Reported Earning Dates

CLGN is expected to report earnings on Aug 22, 2024.

HOOK is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (-1.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CLGN with price predictions.
OPEN
A.I.dvisor published
a Summary for HOOK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HOOK($84.1M) has a higher market cap than CLGN($62M). HOOK YTD gains are higher at: 4.938 vs. CLGN (-15.336).
CLGNHOOKCLGN / HOOK
Capitalization62M84.1M74%
EBITDAN/AN/A-
Gain YTD-15.3364.938-311%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CLGN: Fundamental Ratings
CLGN
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HOOK
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
HOOKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEE66.560.36
+0.54%
Nextera Energy Inc
MREO2.78N/A
N/A
Mereo BioPharma Group plc
GIL35.64-0.08
-0.22%
Gildan Activewear
TCS0.89-0.01
-1.23%
THE Container Store Group
EXPI10.34-0.20
-1.90%
eXp World Holdings